In Focus

Application of Botulinum Toxin Type A

For more than two decades, the Special Hospital for Cerebral Palsy and Developmental Neurology has been providing targeted therapy with Botulinum Toxin Type A to reduce spasticity in specific muscle regions and improve the patients’ functional mobility.